Tiamulin

CAS 55297-95-5 7 current records 1 historicalSmall Molecule

Who holds supplier records for Tiamulin? 7 organisations hold a current record for Tiamulin: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability (8 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: China (3), Bulgaria (1), United States (1), France (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tiamulin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tiamulin

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tiamulin. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Biovet-AD
    BulgariaCEP Company GMP cert on record
  • United StatesCEP
  • Qilu pharmaceutical (Inner Mongolia) Co., Ltd.
    ChinaCEP
  • FranceCEP Company GMP cert on record
  • Suanfarma Italia S.p.A.
    ItalyCEP Company GMP cert on record
  • SUNNY BIOTECH HANGZHOU CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
  • NINGXIA TAIRUI PHARMACEUTICAL CO., LTD
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Tiamulin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Tiamulin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
QILU PHARMACEUTICAL (INNER MONGOLIA) CO. LTD. HULUN BUIR BRANCH Hulun BuirCN
CEP 2022-173 - Rev 01
Tiamulin hydrogen fumarate for veterinary use
May 2026—
SUANFARMA ITALIA S.P.A. RoveretoIT
CEP 2021-471 - Rev 00
Tiamulin hydrogen fumarate for veterinary use
Mar 2024Inspected Dec 2024
Italy
ELANCO ANIMAL HEALTH INCORPORATED GreenfieldUS
R1-CEP 2004-193 - Rev 04
Tiamulin for veterinary use
May 2023—
SAFIC ALCAN PuteauxFR
R1-CEP 2009-063 - Rev 04
Tiamulin hydrogen fumarate for veterinary use
Jun 2022—
SUNNY BIOTECH HANGZHOU CO., LTD. HangzhouCN
R1-CEP 2010-313 - Rev 02
Tiamulin hydrogen fumarate for veterinary use
May 2020—
NINGXIA TAIRUI PHARMACEUTICAL CO., LTD YinchuanCN
R1-CEP 2013-241 - Rev 00
Tiamulin hydrogen fumarate for veterinary use
Sept 2019—
Biovet J. S. C PeshteraBG
R1-CEP 2005-169 - Rev 01
Tiamulin hydrogen fumarate for veterinary use
Sept 2017—
BIOVET J.S.C., RAZGRAD BRANCH RazgradBG
R1-CEP 2010-241 - Rev 01
Tiamulin for veterinary use
Aug 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Tiamulin are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • SANDOZ LTD PHARMACEUTICAL DIV CHEMICAL DEVELOPMENT
    Inactive DMF 5927 · filed Jun 1985

Overview

Tiamulin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1234521).

Chemical identity

IUPAC name
[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-(diethylamino)ethylsulfanyl]acetate
Canonical SMILES
CCN(CC)CCSCC(=O)O[C@@H]1C[C@@]([C@H]([C@@H]([C@@]23CC[C@H]([C@@]1([C@@H]2C(=O)CC3)C)C)C)O)(C)C=C
InChIKey
UURAUHCOJAIIRQ-QGLSALSOSA-N
Synonyms
Denagard, SO 14055, SQ 14055, SQ-14055, Tiamulin, Tiamulina, Tiamuline, Thiamutilin, Tiamulinum, CHEBI:44137, tiamutin, RefChem:56297

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tiamulin?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Tiamulin: Biovet-AD (Bulgaria), ELANCO ANIMAL HEALTH (United States), Qilu pharmaceutical (Inner Mongolia) Co., Ltd. (China), Safic-alcan (France), Suanfarma Italia S.p.A. (Italy), SUNNY BIOTECH HANGZHOU CO., LTD. (China) and NINGXIA TAIRUI PHARMACEUTICAL CO., LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Tiamulin records mean?

1 organisation has only inactive Type II DMFs for Tiamulin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Tiamulin have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Tiamulin on the EDQM register, including QILU PHARMACEUTICAL (INNER MONGOLIA) CO. LTD. HULUN BUIR BRANCH Hulun Buir (CN), SUANFARMA ITALIA S.P.A. Rovereto (IT), ELANCO ANIMAL HEALTH INCORPORATED Greenfield (US), SAFIC ALCAN Puteaux (FR), SUNNY BIOTECH HANGZHOU CO., LTD. Hangzhou (CN) and NINGXIA TAIRUI PHARMACEUTICAL CO., LTD Yinchuan (CN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Tiamulin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tiamulin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.